Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zalcitabine (ddC) vs Zidovudine (AZT) in AIDS or Advanced ARC
NCT00000679Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Primary completion
- Feb 1994
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of zalcitabine in human immunodeficiency virus infection (HIV), acquired immunodeficiency syndrome (AIDS), AIDS-related complex (ARC), sponsored by National Institute of Allergy and Infectious Diseases. Status: completed.
02
Drugs
zalcitabine
03
Conditions
human immunodeficiency virus infection (HIV)acquired immunodeficiency syndrome (AIDS)AIDS-related complex (ARC)
Beyond the preview
Go deeper on NCT00000679.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000679.